Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework

Overview of attention for article published in Health Economics Review, July 2015

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella

Article in PharmacoEconomics (February 2023)

Cost–Benefit Analysis of Human Papillomavirus Vaccine in Iran

Article in Journal of Prevention (August 2022)

Facilitators and barriers of healthcare workers’ recommendation of HPV vaccine for adolescents in Nigeria: views through the lens of theoretical domains framework

Article in BMC Health Services Research (June 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.